| Bioactivity | Evunzekibart (ATOR-1017) is an Fc-γ receptor conditional 4-1BB agonist and IgG4-type antibody. Evunzekibart can be used as monotherapy or in combination with anti-PD1 to exert anticancer activity. |
| Target | 4-1BB/TNFRSF9 |
| Name | Evunzekibart |
| CAS | 2639688-77-8 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |